Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ultraviolet and Visible (UV–Vis) Spectroscopy: Overview01:02

Ultraviolet and Visible (UV–Vis) Spectroscopy: Overview

Ultraviolet–visible (UV–visible or UV–Vis) spectroscopy is an analytical technique that investigates the interaction between matter and UV–Vis light within the electromagnetic spectrum. This method is widely used for its versatility, simplicity, and relatively quick data acquisition, making it valuable for both qualitative and quantitative analysis. When UV–Vis radiation passes through a material,  molecules absorb light depending on the energy required for electronic transitions. As a result...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Photosystem I01:27

Photosystem I

Although structurally similar to photosystem II (PSII), photosystem I (PSI) is has a different electron supplier and electron acceptor.
Both these photosystems work in concert. An excited electron from PSII is relayed to PSI via an electron transport chain in the thylakoid membrane of the chloroplast, which is comprised of the carrier molecule plastoquinone, the dual-protein cytochrome complex, and plastocyanin. As electrons move between PSII and PSI, they lose energy and must be re-energized...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Narrowband vs broadband ultraviolet B phototherapy for adults with moderate-to-severe atopic dermatitis: a randomized controlled trial.

The British journal of dermatology·2026
Same author

Improving Primary Care of Pediatric Atopic Dermatitis: An Analysis of Referrals and Educational Need.

Pediatric dermatology·2026
Same author

Spatially selective multiphoton photothermolysis guided by reflectance confocal microscopy for precise vessel closure in the mouse eye limbus.

Biomedical optics express·2026
Same author

GloW-VSNet: A scribble-based weakly supervised framework for global-view vitiligo lesion segmentation.

Medical image analysis·2025
Same author

The Evolution, Safety, and Public Perception of Sunscreens: A Historical and Contemporary Review.

Photodermatology, photoimmunology & photomedicine·2025
Same author

Integrating Clinical Knowledge Graphs and Gradient-Based Neural Systems for Enhanced Melanoma Diagnosis via the Seven-Point Checklist.

IEEE transactions on neural networks and learning systems·2025

Related Experiment Video

Updated: May 24, 2026

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

UVA1 phototherapy: a concise and practical review.

Soodabeh Zandi1, Sunil Kalia, Harvey Lui

  • 1Psoriasis and Phototherapy Clinic, Vancouver General Hospital, Vancouver, BC, Canada.

Skin Therapy Letter
|February 24, 2012
PubMed
Summary
This summary is machine-generated.

High-intensity long-wavelength ultraviolet A (UVA1) therapy offers a novel approach to treating chronic skin conditions. Its deep dermal penetration and cellular effects provide therapeutic benefits for conditions like atopic dermatitis and morphea.

More Related Videos

An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Related Experiment Videos

Last Updated: May 24, 2026

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

An In Vitro Approach to Photodynamic Therapy
04:53

An In Vitro Approach to Photodynamic Therapy

Published on: August 17, 2018

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
11:39

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

Published on: July 11, 2013

Area of Science:

  • Dermatology
  • Photomedicine
  • Skin Biology

Background:

  • High-intensity long-wavelength ultraviolet A (UVA1) lamps, initially research tools, are now recognized for treating chronic skin diseases.
  • UVA1 phototherapy differs significantly from conventional UV treatments in its units and dosimetry.
  • UVA1's therapeutic efficacy stems from its longer wavelength, enabling deeper penetration into the dermis compared to UVB.

Purpose of the Study:

  • To explore the therapeutic applications and underlying mechanisms of UVA1 in treating chronic dermatoses.
  • To highlight the unique properties of UVA1 phototherapy.
  • To review evidence supporting UVA1's use in various skin conditions.

Main Methods:

  • Utilized high-intensity long-wavelength ultraviolet A (UVA1) lamps.
  • Investigated the effects of UVA1 on dermal components and cellular processes.
  • Reviewed clinical evidence for UVA1 treatment in specific dermatological conditions.

Main Results:

  • UVA1 induces collagenase (matrix metalloproteinase-1) expression and T-cell apoptosis in the dermis.
  • UVA1 depletes Langerhans and mast cells, and stimulates endothelial neovascularization.
  • Significant therapeutic effects observed in atopic dermatitis and morphea.

Conclusions:

  • UVA1 phototherapy demonstrates significant therapeutic potential for chronic skin diseases due to its unique wavelength and biological effects.
  • Evidence supports UVA1's efficacy in atopic dermatitis, morphea, and potentially other conditions like cutaneous T-cell lymphoma and mastocytosis.
  • UVA1 represents a valuable advancement in phototherapy for dermatological treatments.